Our study has examined a longitudinal progression of both amyloid and AT8-positive tau pathology in an animal model simultaneously exhibiting both pathologies characteristic of AD, at different ages, and across a 5-month post injection time window. The gene discussed is MAPT; the disease is Alzheimer disease.